1. Inactive matrix Gla protein is causally related to adverse health outcomes: a Mendelian randomization study in a Flemish population.
- Author
-
Liu YP, Gu YM, Thijs L, Knapen MH, Salvi E, Citterio L, Petit T, Carpini SD, Zhang Z, Jacobs L, Jin Y, Barlassina C, Manunta P, Kuznetsova T, Verhamme P, Struijker-Boudier HA, Cusi D, Vermeer C, and Staessen JA
- Subjects
- Adult, Aged, Aged, 80 and over, Belgium epidemiology, Calcium-Binding Proteins genetics, Calcium-Binding Proteins physiology, Cardiovascular Diseases mortality, Chromosomes, Human, Pair 12 genetics, Environmental Exposure, Extracellular Matrix Proteins genetics, Extracellular Matrix Proteins physiology, Female, Follow-Up Studies, Gene-Environment Interaction, Genotype, Humans, Incidence, Kaplan-Meier Estimate, Linkage Disequilibrium, Male, Mendelian Randomization Analysis, Middle Aged, Neoplasms genetics, Neoplasms mortality, Proportional Hazards Models, Vitamin K Deficiency blood, Vitamin K Deficiency epidemiology, Matrix Gla Protein, Calcium-Binding Proteins blood, Cardiovascular Diseases genetics, Extracellular Matrix Proteins blood, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Protein Processing, Post-Translational
- Abstract
Matrix Gla-protein is a vitamin K-dependent protein that strongly inhibits arterial calcification. Vitamin K deficiency leads to production of inactive nonphosphorylated and uncarboxylated matrix Gla protein (dp-ucMGP). The risk associated with dp-ucMGP in the population is unknown. In a Flemish population study, we measured circulating dp-ucMGP at baseline (1996-2011), genotyped MGP, recorded adverse health outcomes until December 31, 2012, and assessed the multivariable-adjusted associations of adverse health outcomes with dp-ucMGP. We applied a Mendelian randomization analysis using MGP genotypes as instrumental variables. Among 2318 participants, baseline dp-ucMGP averaged 3.61 μg/L. Over 14.1 years (median), 197 deaths occurred, 58 from cancer and 70 from cardiovascular disease; 85 participants experienced a coronary event. The risk of death and non-cancer mortality curvilinearly increased (P≤0.008) by 15.0% (95% confidence interval, 6.9-25.3) and by 21.5% (11.1-32.9) for a doubling of the nadir (1.43 and 0.97 μg/L, respectively). With higher dp-ucMGP, cardiovascular mortality log-linearly increased (hazard ratio for dp-ucMGP doubling, 1.14 [1.01-1.28]; P=0.027), but coronary events log-linearly decreased (0.93 [0.88-0.99]; P=0.021). dp-ucMGP levels were associated (P≤0.001) with MGP variants rs2098435, rs4236, and rs2430692. For non-cancer mortality and coronary events (P≤0.022), but not for total and cardiovascular mortality (P≥0.13), the Mendelian randomization analysis suggested causality. Higher dp-ucMGP predicts total, non-cancer and cardiovascular mortality, but lower coronary risk. For non-cancer mortality and coronary events, these associations are likely causal., (© 2014 American Heart Association, Inc.)
- Published
- 2015
- Full Text
- View/download PDF